Hail, Saudi Arabia

Gheda Alsaif

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Greenway Herbal Products, LLC. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gheda Alsaif: Innovator in Cannabinoid Compositions

Introduction

Gheda Alsaif is a notable inventor based in Hail, Saudi Arabia. He has made significant contributions to the field of cannabinoid research, focusing on compositions and methods that utilize cannabinoids for various therapeutic applications. His work is particularly relevant in the context of treating inflammation, immunosuppression, and cancer.

Latest Patents

Gheda Alsaif holds a patent for cannabinoid compositions and methods of using them. This patent describes compositions that include cannabinoids and outlines methods for their application, such as treating or preventing inflammation, serving as an immunosuppressant, and acting as an anti-cancer therapeutic. The patent includes cannabinoids like CBC, CBCA, CBD, CBDA, CBDV, CBDVA, CBG, CBGA, CBL, CBLA, CBN, CBNA, THCV, THCVA, and combinations thereof, as well as an approximately 1:1 equimolar mixture of CBD:CBDA. He has 1 patent to his name.

Career Highlights

Gheda Alsaif is currently associated with Greenway Herbal Products, LLC, where he continues to innovate in the field of cannabinoid research. His work has the potential to impact various medical treatments and improve patient outcomes.

Collaborations

Gheda collaborates with notable colleagues in his field, including Elliot Altman and Karen Maynard. Their combined expertise contributes to the advancement of cannabinoid research and its applications.

Conclusion

Gheda Alsaif is a pioneering inventor whose work in cannabinoid compositions is paving the way for new therapeutic methods. His contributions are significant in the ongoing exploration of cannabinoids for medical use.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…